Intuitive Surgical Stock Fair Value – Intuitive Surgical: Cutting-Edge Innovation at a Premium Price
April 14, 2023
Trending News ☀️
Intuitive Surgical ($NASDAQ:ISRG), Inc. is an American corporation that develops, manufactures, and markets robotic surgical systems. Their innovative technology is highly sought after due to its accuracy, precision, and ability to reduce the complexity and cost of surgery. Despite the capabilities of their products, Intuitive Surgical comes with a steep price tag. While it can be a costly investment for hospitals and health systems, many have found it to be invaluable when considering the expansive ecosystem that it provides.
From improved outcomes and shorter hospital stays to improved access to care, Intuitive Surgical technology has the potential to revolutionize the healthcare industry. With its cutting-edge technology and wide-ranging ecosystem, Intuitive Surgical is setting the gold standard in robotic surgical systems.
Market Price
Intuitive Surgical has revolutionized surgical procedures with its cutting-edge robotic devices and instruments. On Thursday, INTUITIVE SURGICAL stock opened at $264.0 and closed at $266.6, up by 1.8% from previous closing price of 261.8, confirming that the company’s innovative technology is in high demand. Although the company’s devices come with a premium price tag, its technology has proven to be invaluable for surgeons and patients alike, as it minimizes the risk of complications and improves the precision of operations. The stock’s performance on Thursday further reinforces that Intuitive Surgical is well positioned to remain a leader in the medical technology industry. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Intuitive Surgical. More…
| Total Revenues | Net Income | Net Margin |
| 6.22k | 1.32k | 21.3% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Intuitive Surgical. More…
| Operations | Investing | Financing |
| 1.49k | 1.37k | -2.57k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Intuitive Surgical. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 12.97k | 1.86k | 31.55 |
Key Ratios Snapshot
Some of the financial key ratios for Intuitive Surgical are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 11.6% | 4.7% | 25.3% |
| FCF Margin | ROE | ROA |
| 15.4% | 8.7% | 7.6% |
Analysis – Intuitive Surgical Stock Fair Value
At GoodWhale, we analyzed INTUITIVE SURGICAL‘s fundamentals and found that the intrinsic value of its share is around $306.2, as established with our proprietary Valuation Line algorithm. This means that INTUITIVE SURGICAL is currently trading at $266.6, a fair price that is still undervalued by 12.9%. Our analysis reveals an excellent opportunity for investors to purchase shares of INTUITIVE SURGICAL at a discounted price. More…
Peers
The company’s da Vinci surgical system consists of a surgeon’s console, a patient-side cart and a vision system. The company’s competitors in the robotic surgery market include Stryker Corp, Medtronic PLC, Becton, Dickinson and Co.
– Stryker Corp ($NYSE:SYK)
With a market capitalization of $84.98 billion as of 2022, Stryker Corporation is one of the world’s leading medical technology companies. Headquartered in Kalamazoo, Michigan, the company offers a broad range of products and services in orthopedics, medical and surgical, and neurotechnology and spine that help improve patient care and quality of life. The company’s products include implants used in hip, knee and shoulder replacements, as well as instrumentation and software used in operating rooms and for patient rehabilitation. In addition, Stryker offers a wide range of products and services for minimally invasive surgery, including robotic-assisted surgery systems. The company’s return on equity was 10.79% as of 2022.
– Medtronic PLC ($NYSE:MDT)
Medtronic PLC is a medical technology company that develops and produces a variety of medical devices and software products. The company has a market capitalization of 112.31 billion as of 2022 and a return on equity of 7.49%. Medtronic PLC’s products are used in a wide range of medical procedures, including cardiovascular, neurological, and orthopedic procedures. The company’s products are sold in over 150 countries around the world.
– Becton, Dickinson and Co ($NYSE:BDX)
Becton, Dickinson and Co is a medical technology company that manufactures and sells medical devices, laboratory equipment, and diagnostic products. The company has a market cap of 64.37B as of 2022 and a return on equity of 6.42%. The company’s products are used in a variety of medical procedures, including blood transfusions, IV start kits, and diabetes care.
Summary
Intuitive Surgical is a medical device manufacturer that produces robotic surgical systems. Its innovative technology has made it a leader in the field of robotic surgery, allowing surgeons to perform more precise operations with improved patient outcomes. The company boasts strong financials and a strong competitive advantage in the market. As an investor, Intuitive Surgical offers the potential for high returns with a well-rounded portfolio, as its products are in high demand and the company is well-positioned to benefit from an aging population.
